Livija Deban
Chief Scientific Officer Prokarium
Dr. Livija Deban is Chief Scientific Officer at Prokarium, where she leads the company’s immuno-oncology portfolio. She holds a PhD in Immunology and has extensive experience in cancer immunotherapy and microbiome-based drug development. Before joining Prokarium, Livija served as Vice President of Research at Oxford BioTherapeutics. Her work focuses on leveraging microbial immunotherapy to develop novel treatments for solid tumors, driving Prokarium’s mission to transform cancer care through innovative science.
Seminars
Thursday 29th January 2026
Harnessing Microbial Therapeutics to Prime Immunity & Expand Cancer Treatment Possibilities
2:30 pm
- Explore IO Prime as a strategy to enhance immune readiness and improve response to existing therapies
- Demonstrate how trained immunity and microbial reprogramming can unlock new combination approaches in oncology
- Understand the rationale behind an upcoming trial using attenuated oral salmonella
